NOMINATION AND STANDSTILL AGREEMENTNomination and Standstill Agreement • February 27th, 2014 • Coppersmith Capital Management, LLC • Electromedical & electrotherapeutic apparatus • New York
This Nomination and Standstill Agreement (this “Agreement”), dated February 25, 2014, is by and among the persons and entities listed on Schedule A (collectively, the “Coppersmith Group”, and individually a “Member” of the Coppersmith Group), CONMED Corporation (the “Company”), and Jerome J. Lande (“Lande”) and Curt R. Hartman (“Hartman”), each in his capacity as a Coppersmith Designee (as defined below).
JOINDER AGREEMENTJoinder Agreement • September 21st, 2015 • Coppersmith Capital Management, LLC • Instruments for meas & testing of electricity & elec signals
This JOINDER AGREEMENT (the “Joinder”) is dated as of September 21, 2015 by and among Coppersmith Capital Management, LLC, Scopia Capital Management LP, Jerome J. Lande, Craig Rosenblum, Matthew Sirovich and Jeremy Mindich (collectively, the “Existing Members”) and Coppersmith Value Partners II, LP, Coppersmith Capital Partners, LLC, Scopia Long LLC, Scopia LB LLC, Scopia PX LLC, Scopia Partners LLC, Scopia Windmill Fund LP, Scopia International Master Fund LP, Scopia PX International Master Fund LP, Scopia LB International Master Fund LP, Scopia Long International Master Fund LP, Scopia Capital GP LLC and Scopia Management, Inc. (each a “New Member” and collectively, the “New Members”).
JOINT FILING AGREEMENTJoint Filing Agreement • December 11th, 2015 • Coppersmith Capital Management, LLC • Instruments for meas & testing of electricity & elec signals
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, no par value per share, of Itron, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
TERMINATION OF JOINT FILING AGREEMENT December 10, 2015Termination of Joint Filing Agreement • December 11th, 2015 • Coppersmith Capital Management, LLC • Instruments for meas & testing of electricity & elec signals
Each of the undersigned is a party to that certain Joint Filing Agreement, dated August 5, 2015, as amended on September 21, 2015 and November 4, 2015 (the “Group Agreement”). Each of the undersigned hereby agrees that the Group Agreement is terminated effective immediately.
JOINT FILING AGREEMENTJoint Filing Agreement • September 21st, 2015 • Coppersmith Capital Management, LLC • Instruments for meas & testing of electricity & elec signals
This Agreement (this “Agreement”) is made and entered into as of August 5, 2015, by and among (1) Coppersmith Capital Management, LLC, Jerome J. Lande and Craig Rosenblum (together, “Coppersmith”) and (2) Scopia Capital Management LP, Matthew Sirovich and Jeremy Mindich (together, “Scopia” and with Coppersmith, each a “Party” and, collectively, the “Parties” or the “Group”).
JOINDER AGREEMENTJoinder Agreement • June 17th, 2013 • Coppersmith Capital Management, LLC • In vitro & in vivo diagnostic substances
This JOINDER AGREEMENT (the “Joinder”) is dated as of June 14, 2013 by and among Coppersmith Value Partners, LLC, a Delaware limited liability company, and Scopia Capital Management LLC, a Delaware limited liability company (collectively, the “Existing Members”) and Scopia LB LLC, a Delaware limited liability company (the “New Member”).
JOINT FILING AND SOLICITATION AGREEMENTJoint Filing and Solicitation Agreement • May 9th, 2013 • Coppersmith Capital Management, LLC • In vitro & in vivo diagnostic substances
This Agreement (this “Agreement”) is made and entered into as of March 15, 2013, by and among Coppersmith Value Partners, LLC, a Delaware limited liability company (“Coppersmith”) and Scopia Capital Management LLC, a Delaware limited liability company (“Scopia”) (each a “Party” and, collectively, the “Parties” or the “Group”).
JOINDER AGREEMENTJoinder Agreement • November 4th, 2015 • Coppersmith Capital Management, LLC • Instruments for meas & testing of electricity & elec signals
This JOINDER AGREEMENT (the “Joinder”) is dated as of November 4, 2015 by and among Coppersmith Value Partners II, LP, Coppersmith Capital Partners, LLC, Coppersmith Capital Management, LLC, Jerome J. Lande, Craig Rosenblum, Scopia Long LLC, Scopia LB LLC, Scopia PX LLC, Scopia Partners LLC, Scopia Windmill Fund LP, Scopia International Master Fund LP, Scopia PX International Master Fund LP, Scopia LB International Master Fund LP, Scopia Long International Master Fund LP, Scopia Capital GP LLC, Scopia Capital Management LP, Scopia Management, Inc., Matthew Sirovich and Jeremy Mindich (collectively, the “Existing Members”) and Scopia Long QP LLC (the “New Member”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 6th, 2014 • Coppersmith Capital Management, LLC • Electromedical & electrotherapeutic apparatus
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, par value $0.01 per share, of CONMED Corporation, a New York corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Coppersmith Value Partners, LLC 1370 Sixth Avenue, 25th Floor New York, NY 10019Coppersmith Capital Management, LLC • May 9th, 2013 • In vitro & in vivo diagnostic substances
This letter sets forth our mutual agreement with respect to compensation to be paid to you for your agreement to be named and serve as a nominee of a group of investors (the “Coppersmith Group”), including Coppersmith Value Partners, LLC, for election as a director of Alere Inc. (the “Company”) at the Company’s 2013 annual meeting of shareholders including or any other meeting of shareholders held in lieu thereof, and any adjournments, postponements, reschedulings or continuations thereof, (the “Annual Meeting”).
Coppersmith Value Partners, LLCCoppersmith Capital Management, LLC • August 21st, 2013 • In vitro & in vivo diagnostic substances
Reference is made to that certain Joint Filing and Solicitation Agreement between Coppersmith Value Partners, LLC, a Delaware limited liability company, and Scopia Capital Management LLC, a Delaware limited liability company (together, the “Parties”), dated March 15, 2013 (the “Agreement”).
